These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 6815385)

  • 21. Remission-inducing drugs in rheumatoid arthritis.
    Anastassiades TP
    Can Med Assoc J; 1980 Feb; 122(4):405-15. PubMed ID: 6768438
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Disease-modifying agents in rheumatoid arthritis.
    Lipsky PE
    Ryumachi; 1987 Dec; 27(6):409-12. PubMed ID: 2455354
    [No Abstract]   [Full Text] [Related]  

  • 23. Cyclosporine A in rheumatoid arthritis: results at 30 months.
    Madhok R; Capell HA
    Transplant Proc; 1988 Jun; 20(3 Suppl 4):248-52. PubMed ID: 3132774
    [No Abstract]   [Full Text] [Related]  

  • 24. Serum sulfhydryl levels in rheumatoid patients treated with gold thiomalate and penicillamine.
    Haataja M; Nissilä M; Ruutsalo HM
    Scand J Rheumatol; 1978; 7(4):212-4. PubMed ID: 104378
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Should one use second-line agents such as gold and D-penicillamine in a patient with active rheumatoid arthritis and asymptomatic microscopic haematuria for which no cause can be determined?
    Bird HA
    Br J Rheumatol; 1989 Feb; 28(1):39. PubMed ID: 2492869
    [No Abstract]   [Full Text] [Related]  

  • 26. Do penicillamine and Myocrisin act the same way in rheumatoid arthritis?
    Munthe E; Jellum E; Aaseth J
    Rheumatol Rehabil; 1978; Suppl():105-8. PubMed ID: 103179
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Preliminary results of a controlled study of gold and D-penicillamine therapy in juvenile rheumatoid arthritis (proceedings)].
    Schairer H; Stoeber E; Kölle G
    Z Rheumatol; 1976; 35 Suppl 4():suppl 54-6. PubMed ID: 824885
    [No Abstract]   [Full Text] [Related]  

  • 28. [Possible mechanism of action of drugs in the basic therapy of rheumatoid arthritis: effect on platelet aggregation].
    Fioravanti A; Lolatte V; Giordano N; Frati E; Castagna ML; Morozzi G; Lalumera M; Marcolongo R
    Boll Soc Ital Biol Sper; 1984 May; 60(5):1051-6. PubMed ID: 6432005
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pattern of response to systematised drug therapy in rheumatoid arthritis in Indians.
    Malaviya AN; Khan KM; Tiwari SC
    Indian J Med Res; 1983 May; 77():686-96. PubMed ID: 6413397
    [No Abstract]   [Full Text] [Related]  

  • 30. [Treatment of patients with rheumatoid arthritis with DMARD (disease modifying anti-rheumatic drugs)].
    Halberg P
    Ugeskr Laeger; 1984 Jul; 146(27):1995-2000. PubMed ID: 6440327
    [No Abstract]   [Full Text] [Related]  

  • 31. Drugs for rheumatoid arthritis.
    Med Lett Drugs Ther; 2000 Jul; 42(1082):57-64. PubMed ID: 10887424
    [No Abstract]   [Full Text] [Related]  

  • 32. Sulfasalazine treatment for rheumatoid arthritis: a metaanalysis of 15 randomized trials.
    Weinblatt ME; Reda D; Henderson W; Giobbie-Hurder A; Williams D; Diani A; Docsa S
    J Rheumatol; 1999 Oct; 26(10):2123-30. PubMed ID: 10529127
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Editorial: Gold revalued.
    Lancet; 1974 Apr; 1(7861):789-90. PubMed ID: 4132717
    [No Abstract]   [Full Text] [Related]  

  • 34. Enteric-coated aspirin in rheumatoid arthritis.
    Bird HA; Rhind V; Leatham P; Saunders A; Wright V
    Rheumatol Rehabil; 1981 May; 20(2):116-21. PubMed ID: 6792691
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Antimalarial treatment of rheumatoid arthritis: 1985 status.
    Rynes RI
    J Rheumatol; 1985 Aug; 12(4):657-9. PubMed ID: 4057186
    [No Abstract]   [Full Text] [Related]  

  • 36. Evidence that D-penicillamine alters the course of rheumatoid arthritis.
    Gibson T; Huskisson EC; Wojtulewski JA; Scott PJ; Balme HW; Burry HC; Grahame R; Hart FD
    Rheumatol Rehabil; 1976 Aug; 15(3):211-5. PubMed ID: 823633
    [No Abstract]   [Full Text] [Related]  

  • 37. Trial comparing D-penicillamine and gold in rheumatoid arthritis. Preliminary report.
    Huskisson EC; Gibson TJ; Balme HW; Berry H; Burry HC; Grahame R; Hart FD; Henderson DR; Wojtulewski JA
    Ann Rheum Dis; 1974 Nov; 33(6):532-5. PubMed ID: 4216306
    [No Abstract]   [Full Text] [Related]  

  • 38. [Evaluation of the usefulness of delayed-action preparations in the treatment of rheumatoid polyarthritis by analyzing the therapeutic maintenance dose].
    Dougados M; Nguyen M; Duchesne L; Benjelloun M; Amor B
    Rev Rhum Mal Osteoartic; 1989 Jan; 56(1):89-92. PubMed ID: 2727586
    [No Abstract]   [Full Text] [Related]  

  • 39. Precipitating autoantibody to a ubiquitous tissue antigen: association with rheumatoid arthritis treated with sodium aurothiomalate or d-penicillamine.
    Palosuo T; Kajander A; von Essen R; Milgrom F
    Clin Immunol Immunopathol; 1978 Jul; 10(3):355-64. PubMed ID: 97039
    [No Abstract]   [Full Text] [Related]  

  • 40. Serum histidine in rheumatoid arthritis: changes induced by antirheumatic drug therapy.
    Pickup ME; Dixon JS; Lowe JR; Wright V
    J Rheumatol; 1980; 7(1):71-6. PubMed ID: 7354471
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.